Facial Injectables Market Share

  • Report ID: 4442
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Facial Injectables Market Regional Analysis:

North American Market Insights

North America facial injectables market share is predicted to cross 32% by 2035. This growth of the market in this region is set to be dominated by rising spending on cosmetics. The market in the US for facial injectables is predicted to gather the highest market revenue over the forecast period. This could be owing to the rising number of young population in this region. Additionally, the Canadian market is also set to experience growth in this region on account of the growing consumption of alcohol which is causing premature aging.

APAC Market Insights

Asia Pacific region in facial injectables market is estimated to account for significant revenue share by the end of 2035. The major factor driving the market expansion in this region is the growing middle-class population. As per the predictions of the World Economic Forum, in 2020, over 2 billion population of Asians were middle class and this number is poised to grow to 3.5 billion by 2030. Hence, the spending of the middle-class population is also high on appearance.

Moreover, with the surge in investment in surgical procedures the market in India for facial injectables is projected to have notable growth. Furthermore, the market in South Korea is also expected to expand at a significant pace. This growth is set to be encouraged by a larger number of options available.

Facial Injectables Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of facial injectables is assessed at USD 12.66 billion.

The global facial injectables market size surpassed USD 11.64 billion in 2025 and is projected to witness a CAGR of over 9.7%, crossing USD 29.38 billion revenue by 2035.

The North America facial injectables market is predicted to capture 32% share by 2035, fueled by rising spending on cosmetics and appearance.

Key players in the market include Allergan (AbbVie), Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, Inc., Anika Therapeutics, Inc., BioPlus Co., Ltd., Medytox Inc., Croma-Pharma GmbH.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos